CAH logo

CARDINAL HEALTH INC

CAHNYSE
๐Ÿ† #231 by market capEarnings Aug 11 ยท PreUS Equity
$240.26โ–ฒ $3.12 (+1.30%)
Live
1hโ€”
24hโ–ฒ 1.3%
7dโ€”
14dโ€”
30dโ€”
1yโ€”
๐ŸฆMarket Cap
$56.27B
Mid Cap
๐Ÿ“ˆRevenue Growth (YoY)
+12.9%
Healthy
๐Ÿ“ŠGross Margin
3.8%
Thin
๐Ÿ’ตFCF Margin
1.8%
Thin
โš–๏ธP/S Ratio
0.2x
Cheap
Otter Score
44
Weak
No chart data available for CAH.

Trading Snapshot

Day Range
$237.98 โ€“ $242.08
52-Week Range
$137.75 โ€“ $244.87
Volume
$2.42B
Avg Volume
$2.98B
Shares Outstanding
234.2M
Next Earnings
Oct 7, 2026

Fundamentals Snapshot

Annual Revenue
$63.67B
Last Q Revenue
$60.94B
P/E Ratio
35.6
P/S Ratio
0.2x
EPS (TTM)
$6.54
Dividend Yield
0.89%

Why Investors Own CAH

  • โœ“High-growth profile โ€” revenue up -1.0% YoY with expanding US Equity exposure.
  • โœ“Healthy economics โ€” 77% gross margin and 21% free-cash-flow margin.
  • โœ“New products and segments could unlock additional revenue streams.
โš ๏ธ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$63.67Bโ–ผ โˆ’4.3% YoY
Gross Margin (TTM)
76.6%โ–ฒ +4.1% YoY
Operating Income (TTM)
$16.05Bโ–ผ โˆ’4.3% YoY
Free Cash Flow (TTM)
$13.56Bโ–ผ โˆ’4.3% YoY

About CARDINAL HEALTH INC

Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.

๐Ÿฆฆ

Otter Score Breakdown

โ“˜
๐Ÿ’ŽQualityโ˜…โ˜…โ˜…โ˜…โ˜…
๐Ÿš€Growthโ˜…โ˜…โ˜…โ˜…โ˜…
โš–๏ธValuationโ˜…โ˜…โ˜…โ˜…โ˜…
โšกMomentumโ˜…โ˜…โ˜…โ˜…โ˜…
Overall Score
Weak
44/100

Analyst Ratings

โ“˜
Consensus
Buy
23 analysts
Strong Buy8
Buy12
Hold3
Sell0
Strong Sell0
Ratings as of Aug 2026

Latest News & Updates